Correlation Between Legend Biotech and Synaptogenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Synaptogenix, you can compare the effects of market volatilities on Legend Biotech and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Synaptogenix.

Diversification Opportunities for Legend Biotech and Synaptogenix

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Legend and Synaptogenix is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Legend Biotech i.e., Legend Biotech and Synaptogenix go up and down completely randomly.

Pair Corralation between Legend Biotech and Synaptogenix

Given the investment horizon of 90 days Legend Biotech Corp is expected to generate 0.47 times more return on investment than Synaptogenix. However, Legend Biotech Corp is 2.14 times less risky than Synaptogenix. It trades about -0.05 of its potential returns per unit of risk. Synaptogenix is currently generating about -0.06 per unit of risk. If you would invest  7,225  in Legend Biotech Corp on September 12, 2024 and sell it today you would lose (3,435) from holding Legend Biotech Corp or give up 47.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Legend Biotech Corp  vs.  Synaptogenix

 Performance 
       Timeline  
Legend Biotech Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Synaptogenix 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Synaptogenix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Synaptogenix may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Legend Biotech and Synaptogenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Legend Biotech and Synaptogenix

The main advantage of trading using opposite Legend Biotech and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.
The idea behind Legend Biotech Corp and Synaptogenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world